Search Results 1041-1050 of 17110 for Antagonist

1. Oncology (Medical) - Clinical trials

   The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients who have been ...

2. Open-Label Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab, CIS and GEM; and Compared With CIS and GEM Alone in HA-high Subjects With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma - Mayo Clinic

   The study was conducted to assess the safety and tolerability of (1) polyethylene glycol (PEG) PEGylated Recombinant Human Hyaluronidase (PEGPH20) in ...

3. A Study of Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma - Mayo Clinic

   ... antagonists) within 28 days prior to Week 1, Day 1: Patients who have received acute, low-dose, systemic immunosuppressant medications (e.g., a one-time ...

4. Gastrointestinal stromal tumor (GIST) - Doctors and departments - Mayo Clinic

   Learn about this type of cancer that usually happens in the stomach or small intestine. Treatments often include surgery and targeted therapy.

5. Senescence in Chronic Kidney Disease - Clinical Trials

   Subjects taking H2-antagonists or proton pump inhibitors and unwilling to discontinue therapy for 1 week before and 2 weeks following enrollment. QTc ...

6. Carboplatin and Gemcitabine Hydrochloride With or Without VX-970 in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   ATR kinase inhibitor VX-970 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving carboplatin and gemcitabine with ...

7. Clinical trials - Gastroenterology and Hepatology

   Mayo Clinic's Division of Gastroenterology and Hepatology offers treatment and specialty care for people with a wide range of rare and common digestive ...

8. Discovering Novel Regulators of Myofibroblast Biology - Tissue Repair and Mechanobiology laboratory - Mayo Clinic Research

   The Tissue Repair and Mechanobiology Lab at Mayo Clinic is identifying novel gene and molecular regulators of myofibroblast function in fibrosis.

9. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

10. A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma - Mayo Clinic

    This is a multi-center, open label, single arm phase II study evaluating BGJ398 anti-tumor activity in advanced or metastatic cholangiocarcinoma patients with ...